Free Trial
NYSE:INSP

Inspire Medical Systems (INSP) Stock Price, News & Analysis

Inspire Medical Systems logo
$41.29 -0.90 (-2.12%)
Closing price 06/5/2026 03:59 PM Eastern
Extended Trading
$40.34 -0.95 (-2.30%)
As of 06/5/2026 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Inspire Medical Systems Stock (NYSE:INSP)

Advanced

Key Stats

Today's Range
$41.01
$43.20
50-Day Range
$40.04
$57.58
52-Week Range
$38.91
$147.03
Volume
724,908 shs
Average Volume
1.17 million shs
Market Capitalization
$1.19 billion
P/E Ratio
9.20
Dividend Yield
N/A
Price Target
$81.84
Consensus Rating
Hold

Company Overview

Inspire Medical Systems Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
81st Percentile Overall Score

INSP MarketRank™: 

Inspire Medical Systems scored higher than 81% of companies evaluated by MarketBeat, and ranked 122nd out of 867 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Inspire Medical Systems has received a consensus rating of Hold. The company's average rating score is 2.05, and is based on no strong buy ratings, 4 buy ratings, 13 hold ratings, and 3 sell ratings.

  • Upside Potential

    Inspire Medical Systems has a consensus price target of $81.84, representing about 98.2% upside from its current price of $41.29.

  • Amount of Analyst Coverage

    Inspire Medical Systems has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Inspire Medical Systems' stock forecast and price target.
  • Earnings Growth

    Earnings for Inspire Medical Systems are expected to grow by 59.34% in the coming year, from $0.91 to $1.45 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Inspire Medical Systems is 9.20, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.77.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Inspire Medical Systems is 9.20, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 23.82.

  • Price to Earnings Growth Ratio

    Inspire Medical Systems has a PEG Ratio of 4.36. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Inspire Medical Systems has a P/B Ratio of 1.54. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Inspire Medical Systems' valuation and earnings.
  • Percentage of Shares Shorted

    13.06% of the float of Inspire Medical Systems has been sold short.
  • Short Interest Ratio / Days to Cover

    Inspire Medical Systems has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Inspire Medical Systems has recently increased by 15.50%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Inspire Medical Systems does not currently pay a dividend.

  • Dividend Growth

    Inspire Medical Systems does not have a long track record of dividend growth.

  • News Sentiment

    Inspire Medical Systems has a news sentiment score of 0.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.50 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Inspire Medical Systems this week, compared to 10 articles on an average week.
  • MarketBeat Follows

    4 people have added Inspire Medical Systems to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Inspire Medical Systems insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    2.20% of the stock of Inspire Medical Systems is held by insiders.

  • Percentage Held by Institutions

    94.91% of the stock of Inspire Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Inspire Medical Systems' insider trading history.
Receive INSP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

INSP Stock News Headlines

SpaceX is offering you shares. Don't take them.
SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. But at a $1.75 trillion valuation and 266 times earnings, early institutional holders may be looking for someone to sell to. Dylan Jovine has identified a small company in Musk's supply chain that builds the power infrastructure behind Colossus - still trading at a fraction of its potential value. No IPO allocation required.tc pixel
See More Headlines

INSP Stock Analysis - Frequently Asked Questions

Inspire Medical Systems' stock was trading at $92.20 at the beginning of the year. Since then, INSP shares have decreased by 55.2% and is now trading at $41.2940.

Inspire Medical Systems, Inc. (NYSE:INSP) announced its earnings results on Monday, May, 4th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of ($0.28) by $0.38. Inspire Medical Systems's revenue was up 1.6% compared to the same quarter last year.
Read the conference call transcript
.

Inspire Medical Systems' board approved a share repurchase program on Monday, August 11th 2025, which allows the company to buy back $200,000,000 in shares, according to EventVestor. This means that the company could purchase up to 8.6% of its stock through open market purchases. Stock buyback programs are often a sign that the company's board of directors believes its shares are undervalued.

Inspire Medical Systems (INSP) raised $101 million in an IPO on Thursday, May 3rd 2018. The company issued 6,750,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

Top institutional shareholders of Inspire Medical Systems include Assenagon Asset Management S.A. (1.81%), Renaissance Technologies LLC (1.63%), ADAR1 Capital Management LLC (1.41%) and Amundi (0.89%). Insiders that own company stock include Timothy P Herbert, Richard Buchholz, Shawn Mccormick, John Rondoni, Jerry C Griffin, Randy Ban and Myriam Curet.
View institutional ownership trends
.

Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Inspire Medical Systems investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), UnitedHealth Group (UNH), Tesla (TSLA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ).

Company Calendar

Last Earnings
5/04/2026
Today
6/06/2026
Next Earnings (Estimated)
8/03/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Medical Equipment
Current Symbol
NYSE:INSP
CIK
1609550
Fax
N/A
Employees
1,333
Year Founded
2007

Price Target and Rating

High Price Target
$197.00
Low Price Target
$39.00
Potential Upside/Downside
+98.2%
Consensus Rating
Hold
Rating Score (0-4)
2.05
Research Coverage
20 Analysts

Profitability

EPS (Trailing Twelve Months)
$4.49
Trailing P/E Ratio
9.20
Forward P/E Ratio
45.38
P/E Growth
4.36
Net Income
$145.42 million
Net Margins
14.33%
Pretax Margin
6.99%
Return on Equity
10.35%
Return on Assets
8.81%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.34
Quick Ratio
4.48

Sales & Book Value

Annual Sales
$911.98 million
Price / Sales
1.30
Cash Flow
$2.80 per share
Price / Cash Flow
14.73
Book Value
$26.88 per share
Price / Book
1.54

Miscellaneous

Outstanding Shares
28,810,000
Free Float
28,179,000
Market Cap
$1.19 billion
Optionable
Optionable
Beta
0.73

Social Links

The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NYSE:INSP) was last updated on 6/6/2026 by MarketBeat.com Staff.
From Our Partners